Ultime notizie per Roivant Sciences (NASDAQ:ROIV) Azioni

Roivant Sciences

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Ltd

ROIVANT SCIENCES LTD WT EXP

PrimeEnergy Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNRG#NASDAQ">PNRG</a>) reported quarterly earnings of $8.80 per share. This is a 113.08 percent increase over earnings of $4.13 per share from the same period last year. The company reported $69.45 million in sales this quarter. This is a 84.84 percent increase over sales of $37.58 million the same period last year.

Earnings

News

PNRG

PrimeEnergy Resources Q3 EPS $8.80 Up From $4.13 YoY, Sales $69.45M Up From $37.58M YoY

WIIM

OWLT

Owlet shares are trading lower after the company reported worse-than-expected Q3 revenue results.

<a href="https://www.youtube.com/live/Oy1vB7UCzTE?si=Y6G0zJHkoYw0dwRm" title="https://www.youtube.com/live/Oy1vB7UCzTE?si=Y6G0zJHkoYw0dwRm">https://www.youtube.com/live/Oy1vB7UCzTE?si=Y6G0zJHkoYw0dwRm</a>

Federal Reserve

Fed Chair Powell Says Productivity Growth Is Very Positive, Hope It Continues, No Reason Why It Can't; Historically Productivity Growth Tends To Quickly Return To Trend Though

BCAB

BioAtla shares are trading lower. The stock may be reacting to the Scion Asset Management 13F filing disclosing an exit from their position in the company.

BNTX

MRNA

NVAX

Shares of vaccine stocks are trading lower following a report suggesting president-elect Trump is expected to nominate Robert F. Kennedy Jr. to lead the HHS.

<a href="https://www.youtube.com/watch?v=Oy1vB7UCzTE" title="https://www.youtube.com/watch?v=Oy1vB7UCzTE">https://www.youtube.com/watch?v=Oy1vB7UCzTE</a>

Macro Economic Events

Economics

Fed Chair Powell Says We Reserve Judgment On Effect Of New Policies; Important To Wait And See What Actually Happens; We Will Do What We Believe Is The Right Thing, But Need To See How This Plays Out; Surge In Immigration 2023-2024 May Have Helped Get Labor Market In Better Balance

<a href="https://www.politico.com/news/2024/11/14/robert-f-kennedy-jr-trump-hhs-secretary-pick-00188617">https://www.politico.com/news/2024/11/14/robert-f-kennedy-jr-trump-hhs-secretary-pick-00188617</a>
&nbsp;
President-elect Donald Trump is expected to nominate former presidential candidate and anti-vaccine activist Robert F. Kennedy Jr. to lead the Department of Health and Human Services, according to a person with direct knowledge of the selection.
The expected pick, which will roil many public health experts, comes after Trump promised to let Kennedy <a href="https://www.politico.com/video/2024/10/28/trump-says-he-would-let-rfk-jr-go-wild-on-medicines-1466853">"go wild" with health</a> and food policy in his administration after Kennedy dropped his own presidential bid to endorse the now-president-elect. It's also a sign of the opening Trump sees after he scored a decisive electoral victory and Republicans won a comfortable majority in the Senate.
Trump could still select someone else for the post. The Trump transition couldn't immediately be reached for comment.
"He's going to help make America healthy again. … He wants to do some things, and we're going to let him get to it," Trump said in his victory speech. "Go have a good time, Bobby."

Politics

Trading Ideas

General

'Trump Expected To Select Robert F. Kennedy Jr. To Lead HHS; The Choice Will Roil Many Public Health Experts After His Years Of Touting Debunked Claims That Vaccines Cause Autism' - Politico

FGEN

FibreGen shares are trading higher. The stock may be moving on continued strength following a Q3 earnings beat reported on Tuesday.

Fed Chair Powell Says Treasury Market Functions Very Well; In The Case Of A Financial Stability Event, Fed Can Use Emergency Tools; Fed Needs To Look At Net Effect Of Any New Policies; It's Not Common That Changes In Govt Policy Have Immediate Effects In Achievement Of Goals; We Will Be Careful To Better Understand Net Effect Of Policies, As They Affect Achievement Of Fed Goals

RKDA

Arcadia Biosciences shares are trading lower. The stock may be moving on continued weakness following a Q3 earnings miss reported on Tuesday.

Brace yourselves: the <a href="https://www.benzinga.com/personal-finance/24/10/41297994/the-great-wealth-transfer-is-here-but-millennials-are-also-stuck-with-the-great-stuff-transfer">"Great Wealth Transfer"</a> is officially happening, according to reports. Over the next 20 years, $84 trillion will pass from Baby Boomers to younger generations. But most people aren't prepared to manage it.&nbsp;
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace –<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li><a href="https://www.benzinga.com/money/100k-cd">$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</a></li>
</ul>
Michael Pelzar, head of investments at Bank of America Private Bank, told Yahoo Finance, "Nearly half of wealthy families don't have the most basic elements of estate planning in place. What that means is that families are woefully underprepared for that wealth transfer that'll be taking place." Translation? America is heading into the largest wealth shift in history and many families are flying blind.
According to a recent survey by Citizens Bank, 72% of Americans aren't confident they can handle a <a href="https://www.benzinga.com/personal-finance/24/09/40711869/how-rich-are-you-heres-the-net-worth-that-defines-upper-middle-and-lower-class">major influx of money</a> on their own. And it's not just a few nervous individuals – only 42% of adults expecting an inheritance feel comfortable managing new wealth.&nbsp;
Even with so much on the line, family discussions about wealth transfer aren't happening. A surprising 35% of Americans admit they have no plans to <a href="https://www.benzinga.com/personal-finance/24/10/41555075/millennials-and-gen-z-rely-on-parents-for-financial-support-survey-finds-its-costing-them-their-">discuss inheritance with their families</a>. That's a significant gap, considering that only 27% have sat down to discuss it. And without these conversations, <a href="https://www.benzinga.com/personal-finance/24/10/41238204/can-you-guess-what-it-takes-to-join-the-top-4-of-households-heres-a-hint-its-not-as-high-as-youd">critical planning often gets left in the dark</a>.
Trending: Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a>
The <a href="https://www.benzinga.com/personal-finance/24/07/39749369/financial-illiteracy-epidemic-57-of-americans-cant-even-score-50-on-a-financial-literacy-test">lack of estate planning is a huge issue</a> if it isn't clear. Nearly half of affluent families have skipped out on even the most basic measures. The situation is even worse for younger generations: 62% of millennials don't have a will or trust in place. And yes, these are the same millennials (55%) expecting to inherit within the next five years.
Regarding probate – the legal process of handling estates after death – 65% of Americans know the term, but only a few understand it. Meanwhile, 56% of Americans have no idea about the fees involved. Spoiler: probate isn't cheap.
While 57% of Americans say they'd be more comfortable with a professional guiding family wealth discussions, younger adults have a different approach. Increasingly, Gen Z and millennials are relying on social media for financial advice instead of, say, a certified advisor. Sure, TikTok is a gold mine of info, but it's probably not the best place to manage a family's estate plan.
With so much at stake, now's the time to ensure your financial plans are solid. Whether organizing an estate, building confidence around a future inheritance or just setting up the basics like a will, a <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">financial advisor can help</a> simplify the process and reduce potential headaches. And remember – you don't need to be ultra-wealthy to benefit from smart planning.&nbsp;
Read Next:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>

Personal Finance

The Greatest Wealth Transfer in History Is Here, But 72% of Americans Say They're Not Ready For It

Atmos Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATO#NYSE">ATO</a>) short percent of float has fallen 3.76% since its last report. The company recently reported that it has 4.85 million shares sold short, which is 4.1% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.96 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Atmos Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731616222_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Atmos Energy has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Atmos Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Atmos Energy's peer group average for short interest as a percentage of float is 3.34%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Atmos Energy?

Comcast's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NYSE">CMCSA</a>) short percent of float has risen 7.28% since its last report. The company recently reported that it has 61.28 million shares sold short, which is 1.62% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.2 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Comcast Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731616217_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Comcast has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Comcast's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Comcast's peer group average for short interest as a percentage of float is 9.85%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CMCSA

How Is The Market Feeling About Comcast?

Copart's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NYSE">CPRT</a>) short percent of float has fallen 8.67% since its last report. The company recently reported that it has 12.34 million shares sold short, which is 1.58% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.55 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Copart Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731616212_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Copart has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Copart's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Copart's peer group average for short interest as a percentage of float is 4.25%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CPRT

Peering Into Copart's Recent Short Interest

Comp En De Mn Cemig American Depositary Shares Resume Trade

GRFS

Grifols shares are trading higher following a report suggesting banks are preparing to submit final offers for a buyout debt deal.

PCYO

Pure Cycle shares are trading higher after the company reported a year-over-year increase in Q4 financial results.

BCDA

BioCardia shares are trading higher. The company reported Q3 financial results.

Fed Chair Powell Says When It Comes To Fiscal Policy It Takes A Long Time To Get A Bill Through; We Have Time To Make Assessments On Net Effects Of Policy Changes Before We React With Policy; Analysis Will Come Before That; We Will Be Careful About Changing Policy Until We Have A Lot More Certainty; Not In Any Way Taking Into Account Fiscal Issues, The Debt Issue Does Not Guide Us In Making Judgments; Debt Path Is Not Sustainable; Need To Address That Sooner Than Later

On Tuesday, the U.S. Justice Department said it will block UnitedHealth Group Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) multi-billion&nbsp;acquisition of&nbsp;Amedisys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMED#NASDAQ">AMED</a>).
The Justice Department has sued to block UnitedHealth&#8217;s $3.3 billion purchase of healthcare services company Amedisys, citing concerns about competition in the home <a target="_blank" href="https://www.benzinga.com/news/legal/24/11/41917050/justice-department-moves-to-block-unitedhealths-amedisys-takeover-whats-going-on" rel="noreferrer noopener">health services market</a>.
UnitedHealth&#8217;s Optum unit&nbsp;launched a website&nbsp;that aims to highlight the benefits of the combination. The website <a target="_blank" href="https://www.improvinghomecare.com/" rel="noreferrer noopener">notes</a> that the home healthcare industry remains highly fragmented despite the growing market.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/24/11/41866438/donald-trumps-second-term-could-reshape-us-healthcare-system-with-major-impacts-on-affordable-care-act-and-medicare" rel="noreferrer noopener">Donald Trump&#8217;s Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare</a>
On average, 26 agencies compete in metropolitan areas with about 500,000 residents, highlighting the range of available care options.
In 2020, approximately 3 million Americans received home health care, a figure expected to grow as the population ages.
By 2030, 18% of the U.S. population will be 65 or older, a significant increase from 13% in 2021.
This demographic shift underscores the necessity for expanded home health services that allow older adults to remain in their homes.
The merger between Optum and Amedisys represents a strategic move to address these needs.
While this combined entity would represent only a portion of the overall home health and hospice care market, the competitive landscape is expected to remain robust.
To promote competition and prevent market dominance, Optum and Amedisys have agreed to divest numerous home health and hospice centers to VitalCaring upon the transaction&#8217;s completion.
VitalCaring currently operates at around 58 locations across six states.
Price Action: UNH stock is down 2.76% at $589.17 at the last check Thursday
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41979149/general-motors-faces-recall-crisis-with-faulty-transmissions-details" target="_blank" rel="noreferrer noopener">General Motors Faces Recall Crisis With Faulty Transmissions: Details</a></li>
</ul>
Image via Shutterstock

Large Cap

Health Care

Legal

AMED

UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape

Organon (OGN) announced completion of its acquisition of Dermavant Sciencesfrom Roivant (ROIV). Dermavant is a company dedicated to developing and ...

Organon completes acquisition of Dermavant

Roivant Sciences ( ($ROIV) ) has shared an update. Organon has successfully acquired Dermavant Sciences, expanding its dermatology portfolio with t...

Roivant Sciences Acquires Dermavant, Expanding Dermatology Portfolio

TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) today. The company's shares closed yesterday at ...

Roivant Sciences (ROIV) Receives a Buy from TD Cowen

Here's the major earnings before the open tomorrow

Reports Q2 revenue $4.47M vs $3.648M last year. "I am pleased to finish out another quarter with continued clinical execution, including positive d...

Roivant Sciences reports Q2 EPS (31c), consensus (26c)

Roivant Sciences Ltd. 2025 Q2 - Results - Earnings Call Presentation

Roivant Sciences Ltd. 2024 Q2 - Results - Earnings Call Presentation

Roivant Sciences Ltd. (ROIV) Q2 2024 Earnings Call Transcript

TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) yesterday. The company's shares closed yesterday...

TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV)

Leerink Partners analyst David Risinger has reiterated their bullish stance on ROIV stock, giving a Buy rating yesterday. David Risinger has given ...

Positive Outlook on Roivant Sciences: Buy Rating Justified by Strong Cash Position and Promising Pipeline Developments

ACTG

AGEN

AMTX

AUTL

AXSM

BAYZF

BIOX

BITF

BLDE

BWAY

BXSL

CAMT

CBAT

CCLD

CGEN

CRON

CVAC

DAVA

EVGO

FLNG

FOUR

GENI

GLNG

HUYA

KOPN

LEGN

LFWD

MIRM

NSPR

ONON

PLUG

RAIL

RGEN

RGTI

ROIV

SATS

SDGR

SFTBY

SHLS

SHOP

SLVM

SOHO

SOHU

SPHR

TIGR

VERI

ZLAB

Press Releases

H.C. Wainwright Announces 26th Annual Global Investment Conference, September 9-11, 2024. Event Features Leading Industry Keynote Addresses by Vivek Ramaswamy, Michael Saylor; Bitcoin Panel Moderated by Anthony Scaramucci.

Roivant Provides Update on Graves' Disease Development Program

Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress

Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update

Comments

Roivant Sciences

Notizie

Ultime notizie per Roivant Sciences (NASDAQ:ROIV) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO